For gut or GI healing, stick with BPC-157 only
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
Szutowicz A, Bielarczyk H, Ronowska A, Gul-Hinc S, Klimaszewska-Tata J, Dys A, et al
This is the Colleges Research Roundupa quarterly news feature that allows us to celebrate the success of these students and their work
Modifier 59 applies to the second injection when multiple distinct injections are given
Current Pharmaceutical Design, 2011